Le JDB : Ludovic Lastennet (Implanet), Jamila El Bougrini (Invest Securities)

from Le Journal des Biotechs · host BOURSORAMA

Dans ce numéro du journal des biotechs, Jamila El Bougrini, analyste chez Invest Securities, revient sur l'actualité de Gensight, Quantum Genomics, OSE et Adocia.L'entretien est consacré à Ludovic Lastennet. Le directeur général d'Implanet détaille le partenariat avec Sanyou Medical, la levée de fonds en cours et les perspectives de la medtech.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published Oct 5, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Le JDB : Ludovic Lastennet (Implanet), Jamila El Bougrini (Invest Securities)

0:00 29:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Le Journal des Biotechs?

This episode is 29 minutes long.

When was this Le Journal des Biotechs episode published?

This episode was published on October 5, 2022.

Can I download this Le Journal des Biotechs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!